Production of endothelial progenitor cells from skin fibroblasts by direct reprogramming for clinical usages
Endothelial progenitor cells (EPCs) play an important role in angiogenesis. However, they exist in limited numbers in the human body. This study was aimed to produce EPCs, for autologous transplantation, using direct reprogramming of skin fibroblasts under GMP-compliant conditions. Fibroblasts were collected and cultured from the skin in DMEM/F12 medium supplemented with 5% activated platelet-rich plasma and 1% antibiotic-antimycotic solution. They were then transfected with mRNA ETV2 and incubated in culture medium under hypoxia (5% oxygen) for 14 d. Phenotype analysis of transfected cells confirmed that single-factor ETV2 transfection successfully reprogrammed dermal fibroblasts into functional EPCs. Our results showed that ETV2 mRNA combined with hypoxia can give rise to functional EPCs. The cells exhibited functional phenotypes similar to endothelial cells derived from umbilical cord vein; they expressed CD31 and VEGFR2, and formed capillary-like structures in vitro. Moreover, these EPCs could significantly improve hindlimb ischemia in mouse models. Although the direct conversion efficacy was low (3.12 ± 0.98%), altogether our study demonstrates that functional EPCs can be produced from fibroblasts and can be used in clinical applications.
KeywordsEndothelial progenitor cells Direct conversion ETV2 Hindlimb ischemia Ischemia Stem cell therapy Epigenetic reprogramming
This research was funded by the Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106-YS.06-2013.37.
The authors declare they have no competing interests.
- Bogoslovsky T, Wang D, Maric D, Scattergood-Keepper L, Spatz M, Auh S, Hallenbeck J (2013) Cryopreservation and enumeration of human endothelial progenitor and endothelial cells for clinical trials. J Blood Disord Transfus 4Google Scholar
- Borch TH, Engell-Noerregaard L, Zeeberg Iversen T, Ellebaek E, Met Ö, Hansen M, Andersen MH, Thor Straten P, Svane IM (2016) mRNA transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma. Onco Immunol :00–00Google Scholar
- Coosemans A, Tuyaerts S, Morias K, Corthals J, Heirman C, Thielemans K, Van Gool SW, Vergote I, Amant F (2016) mRNA electroporation of dendritic cells with WT1, survivin, and TriMix (a mixture of caTLR4, CD40L, and CD70). Synthetic mRNA: production, introduction into cells, and physiological consequences, pp 277–283Google Scholar
- D'Avola D, Fernandez-Ruiz V, Carmona-Torre F, Mendez M, Perez-Calvo J, Prosper F, Andreu E, Herrero JI, Inarrairaegui M, Fuertes C, et al. (2016) Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow-derived endothelial progenitor cells. Transl ResGoogle Scholar
- Franca CN, Amaral JB, Tuleta ID, Siviero F, Ferreira CE, Izar MC, Fonseca FA (2016) Challenges facing the use of endothelial progenitor cells in stem cell therapies. Crit Rev Eukaryot Gene Expr 26Google Scholar
- Jamiolkowski RM, Kang SD, Rodriguez AK, Haseltine JM, Galinat LJ, Jantzen AE, Carlon TA, Darrabie MD, Arciniegas AJ, Mantilla JG et al (2015) Increased yield of endothelial cells from peripheral blood for cell therapies and tissue engineering. Regen Med 10:447–460CrossRefPubMedPubMedCentralGoogle Scholar
- Jin Y, Seo J, Lee JS, Shin S, Park HJ, Min S, Cheong E, Lee T, Cho SW (2016) Triboelectric nanogenerator accelerates highly efficient nonviral direct conversion and in vivo reprogramming of fibroblasts to functional neuronal cells. Adv MaterGoogle Scholar
- Le PM, Tran TT-B, Vu BT, Van Pham P (2016) A preliminary comparison of dendritic cell maturation by total cellular RNA to total cellular lysate derived from breast cancer stem cells. Biomedical Research and Therapy 3:679–686Google Scholar
- Margariti A, Winkler B, Karamariti E, Zampetaki A, Tsai TN, Baban D, Ragoussis J, Huang Y, Han JD, Zeng L et al (2012) Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc Natl Acad Sci U S A 109:13793–13798CrossRefPubMedPubMedCentralGoogle Scholar
- Pham PV, Vu NB, Phan NLC, Le DM, Truong NC, Truong NH, Bui KHT, Phan NK (2014b) Good manufacturing practice-compliant isolation and culture of human adipose-derived stem cells. 2014 1:9Google Scholar
- Suh W, Kim KL, Kim JM, Shin IS, Lee YS, Lee JY, Jang HS, Lee JS, Byun J, Choi JH et al (2005) Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 23:1571–1578CrossRefPubMedGoogle Scholar
- Telpalo-Carpio SA, Díaz-Mitoma F, Moreno-Cuevas JE, Aguilar-Yanez JM (2016) Direct comparison of DNA versus mRNA on the efficiency of induced pluripotent stem cells generation from human primary fibroblasts. Cell Mol Med Open AccessGoogle Scholar
- Van Pham P, Vu NB, Nguyen HT, Phan NK (2016c) Isolation of endothelial progenitor cells from human adipose tissue. Biomedical Research and Therapy 3:645–652Google Scholar
- Vu NB, Bui ANT, Ngoc-Le Trinh V, Phi LT, Phan NK, Van Pham P (2014) A comparison of umbilical cord blood-derived endothelial progenitor and mononuclear cell transplantation for the treatment of acute hindlimb ischemiaGoogle Scholar
- Wang Y, Fan L, Meng X, Jiang F, Chen Q, Zhang Z, Yan H (2016) Transplantation of IL-10-transfected endothelial progenitor cells improves retinal vascular repair via suppressing inflammation in diabetic rats. Graefes Arch Clin Exp OphthalmolGoogle Scholar
- Zhang Y, Chen Z, Wang T, Yang J, Li R, Wang S, Liu J, Ye Z (2016) Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase. OncotargetGoogle Scholar